Your browser doesn't support javascript.
Pulse oximetry and oxygen services for the care of children with pneumonia attending frontline health facilities in Lagos, Nigeria (INSPIRING-Lagos): study protocol for a mixed-methods evaluation.
Graham, Hamish R; Olojede, Omotayo E; Bakare, Ayobami Adebayo A; McCollum, Eric D; Iuliano, Agnese; Isah, Adamu; Osebi, Adams; Seriki, Ibrahim; Ahmed, Tahlil; Ahmar, Samy; Cassar, Christine; Valentine, Paula; Olowookere, Temitayo Folorunso; MacCalla, Matt; Uchendu, Obioma; Burgess, Rochelle Ann; Colbourn, Timothy; King, Carina; Falade, Adegoke G.
  • Graham HR; Centre for International Child Health, MCRI, University of Melbourne, The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia hamish.graham@rch.org.au.
  • Olojede OE; Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
  • Bakare AAA; Department of Paediatrics, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
  • McCollum ED; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
  • Iuliano A; Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
  • Isah A; Eudowood Division of Pediatric Respiratory Sciences, Department of Paediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
  • Osebi A; Institute for Global Health, University College London, London, UK.
  • Seriki I; Save the Children International, Abuja, FCT, Nigeria.
  • Ahmed T; Save the Children International, Abuja, FCT, Nigeria.
  • Ahmar S; Save the Children International, Abuja, FCT, Nigeria.
  • Cassar C; Save the Children Fund, London, UK.
  • Valentine P; Save the Children Fund, London, UK.
  • Olowookere TF; Save the Children Fund, London, UK.
  • MacCalla M; Save the Children Fund, London, UK.
  • Uchendu O; GlaxoSmithKline (GSK), Lagos, Nigeria.
  • Burgess RA; GlaxoSmithKline (GSK), Brentford, UK.
  • Colbourn T; Department of Community Medicine, University College Hospital Ibadan, Ibadan, Oyo, Nigeria.
  • King C; Department of Community Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
  • Falade AG; Institute for Global Health, University College London, London, UK.
BMJ Open ; 12(5): e058901, 2022 05 02.
Article in English | MEDLINE | ID: covidwho-1891834
ABSTRACT

INTRODUCTION:

The aim of this evaluation is to understand whether introducing stabilisation rooms equipped with pulse oximetry and oxygen systems to frontline health facilities in Ikorodu, Lagos State, alongside healthcare worker (HCW) training improves the quality of care for children with pneumonia aged 0-59 months. We will explore to what extent, how, for whom and in what contexts the intervention works. METHODS AND

ANALYSIS:

Quasi-experimental time-series impact evaluation with embedded mixed-methods process and economic evaluation.

SETTING:

seven government primary care facilities, seven private health facilities, two government secondary care facilities. TARGET POPULATION children aged 0-59 months with clinically diagnosed pneumonia and/or suspected or confirmed COVID-19. INTERVENTION 'stabilisation rooms' within participating primary care facilities in Ikorodu local government area, designed to allow for short-term oxygen delivery for children with hypoxaemia prior to transfer to hospital, alongside HCW training on integrated management of childhood illness, pulse oximetry and oxygen therapy, immunisation and nutrition. Secondary facilities will also receive training and equipment for oxygen and pulse oximetry to ensure minimum standard of care is available for referred children. PRIMARY

OUTCOME:

correct management of hypoxaemic pneumonia including administration of oxygen therapy, referral and presentation to hospital. SECONDARY

OUTCOME:

14-day pneumonia case fatality rate. Evaluation period August 2020 to September 2022. ETHICS AND DISSEMINATION Ethical approval from University of Ibadan, Lagos State and University College London. Ongoing engagement with government and other key stakeholders during the project. Local dissemination events will be held with the State Ministry of Health at the end of the project (December 2022). We will publish the main impact results, process evaluation and economic evaluation results as open-access academic publications in international journals. TRIAL REGISTRATION NUMBER ACTRN12621001071819; Registered on the Australian and New Zealand Clinical Trials Registry.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: Africa / Oceania Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-058901

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: Africa / Oceania Language: English Journal: BMJ Open Year: 2022 Document Type: Article Affiliation country: Bmjopen-2021-058901